drug protocol number

D3250R0011

drug sponsor

AstraZeneca

drug study

Benralizumab

drug trial site

King Fahad Medical City (Riyadh) , King Faisal Specialist Hospital and Research Center (Jeddah),International Medical Center (Jeddah)

drug status

Ongoing

drug phase